ABCB vs BRK-B

ABCB exhibits mixed financial health with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, and no available Altman Z-Score limits distress risk assessment. The stock trades below its growth-based intrinsic value of $97.33 at $80.44, supported by strong profitability margins and consistent earnings beats, though recent Q/Q EPS decline and weak technical trend raise concerns. Valuation remains attractive relative to sector peers with a P/E of 14.34 vs. sector average of 21.22, while low dividend strength and lack of insider activity temper bullishness. Growth is moderate with 6.9% YoY earnings growth, but technical indicators and near-term deceleration suggest caution despite solid historical performance.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.